International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005

被引:47
作者
Bruce, Michael G. [1 ]
Deeks, Shelley L. [2 ]
Zulz, Tammy [1 ]
Bruden, Dana [1 ]
Navarro, Christine [2 ]
Lovgren, Marguerite [3 ]
Jette, Louise [4 ]
Kristinsson, Karl [5 ]
Sigmundsdottir, Gudrun
Brinklov, Knud [6 ]
Lovoll, Oistein [7 ]
Nuorti, J. Pekka [8 ]
Herva, Eija [9 ]
Nystedt, Anders [10 ]
Sjostedt, Anders [11 ]
Koch, Anders [12 ]
Hennessy, Thomas W. [1 ]
Parkinson, Alan J. [1 ]
机构
[1] Ctr Dis Control & Prevent, Anchorage, AK USA
[2] Publ Hlth Agcy Canada, Ottawa, ON, Canada
[3] Natl Ctr Streptococcus, Edmonton, AB, Canada
[4] Quebec Publ Hlth Lab, Quebec City, PQ, Canada
[5] Landspitali Univ Hosp, Reykjavik, Iceland
[6] Inst Chief Med Officer, Nuuk, Greenland
[7] Norwegian Inst Publ Hlth, Oslo, Norway
[8] Natl Publ Hlth Inst, Helsinki, Finland
[9] Natl Publ Hlth Inst, Oulu, Finland
[10] Sunderby Hosp, Lulea, Sweden
[11] Umea Univ, Umea, Sweden
[12] Statens Serum Inst, DK-2300 Copenhagen, Denmark
关键词
D O I
10.3201/eid1401.071315
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The International Circumpolar Surveillance System is a population-based surveillance network for invasive bacterial disease in the Arctic. The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced for routine infant vaccination in Alaska (2001), northern Canada (2002-2006), and Norway (2006). Data for invasive pneumococcal disease (IPD) were analyzed to identify clinical findings, disease rates, serotype distribution, and antimicrobial drug susceptibility; 11,244 IPD cases were reported. Pneumonia and bacteremia were common clinical findings. Rates of IPD among indigenous persons in Alaska and northern Canada were 43 and 38 cases per 100,000 population, respectively. Rates in children <2 years of age ranged from 21 to 153 cases per 100,000 population. In Alaska and northern Canada, IPD rates in children <2 years of age caused by PCV7 serotypes decreased by >80% after routine vaccination. IPD rates are high among indigenous persons and children in Arctic countries. After vaccine introduction, IPD caused by non-PCV7 serotypes increased in Alaska.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 30 条
[1]  
Butler J C, 1999, Alaska Med, V41, P35
[2]   Invasive pneumococcal disease in Greenland [J].
Christiansen, J ;
Poulsen, P ;
Ladefoged, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (05) :325-329
[3]   HIGH-INCIDENCE RATES OF INVASIVE PNEUMOCOCCAL DISEASE IN THE WHITE MOUNTAIN APACHE POPULATION [J].
CORTESE, MM ;
WOLFF, M ;
ALMEIDOHILL, J ;
REID, R ;
KETCHAM, J ;
SANTOSHAM, M .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (11) :2277-2282
[4]  
Dahl MS, 2001, SCAND J INFECT DIS, V33, P667, DOI 10.1080/00365540110026818
[5]   THE EPIDEMIOLOGY OF INVASIVE PNEUMOCOCCAL DISEASE IN ALASKA, 1986-1990 - ETHNIC-DIFFERENCES AND OPPORTUNITIES FOR PREVENTION [J].
DAVIDSON, M ;
PARKINSON, AJ ;
BULKOW, LR ;
FITZGERALD, MA ;
PETERS, HV ;
PARKS, DJ .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :368-376
[6]   Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections [J].
Flannery, B ;
Schrag, S ;
Bennett, NA ;
Lynfield, R ;
Harrison, LH ;
Reingold, A ;
Cieslak, PR ;
Hadler, J ;
Farley, MM ;
Facklam, RR ;
Zell, ER ;
Whitney, CG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (18) :2197-2203
[7]   A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: Implications for vaccine choice [J].
Fraser, D ;
Givon-Lavi, N ;
Bilenko, N ;
Dagan, R .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :421-427
[8]   Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity [J].
Hennessy, TW ;
Singleton, RJ ;
Bulkow, LR ;
Bruden, DL ;
Hurlburt, DA ;
Parks, D ;
Moore, M ;
Parkinson, AJ ;
Schuchat, A ;
Butler, JC .
VACCINE, 2005, 23 (48-49) :5464-5473
[9]   Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US - An update [J].
Karchmer, AW .
CLINICAL INFECTIOUS DISEASES, 2004, 39 :S142-S150
[10]  
KOCH A, IN PRESS HLTH TRANSI